Matrix Private Capital Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$350K Hold
1,608
0.17% 71
2025
Q4
$367K Buy
1,608
+10
+0.6% +$2.28K 0.19% 66
2025
Q3
$370K Hold
1,598
0.2% 63
2025
Q2
$297K Sell
1,598
-64
-4% -$11.9K 0.17% 74
2025
Q1
$348K Sell
1,662
-218
-12% -$42.4K 0.21% 71
2024
Q4
$334K Hold
1,880
0.19% 76
2024
Q3
$371K Sell
1,880
-250
-12% -$46.7K 0.21% 69
2024
Q2
$365K Buy
2,130
+29
+1% +$4.8K 0.23% 70
2024
Q1
$383K Hold
2,101
0.26% 67
2023
Q4
$326K Hold
2,101
0.25% 68
2023
Q3
$313K Hold
2,101
0.23% 68
2023
Q2
$283K Sell
2,101
-38
-2% -$5.57K 0.21% 80
2023
Q1
$341K Sell
2,139
-110
-5% -$16.8K 0.24% 76
2022
Q4
$363K Sell
2,249
-199
-8% -$30.5K 0.24% 85
2022
Q3
$329K Sell
2,448
-612
-20% -$87.8K 0.22% 87
2022
Q2
$469K Buy
3,060
+78
+3% +$11.9K 0.27% 80
2022
Q1
$483K Buy
2,982
+143
+5% +$20.8K 0.24% 84
2021
Q4
$384K Buy
2,839
+687
+32% +$81.2K 0.18% 106
2021
Q3
$232K Sell
2,152
-221
-9% -$25.3K 0.12% 153
2021
Q2
$267K Hold
2,373
0.15% 141
2021
Q1
$257K Buy
2,373
+504
+27% +$53.9K 0.15% 145
2020
Q4
$200K Buy
+1,869
New +$180K 0.14% 154

Other funds holding ABBV

Matrix Private Capital Group's ABBV Position: Q1 2026 in Review

Matrix Private Capital Group held its AbbVie (ABBV) position steady in Q1 2026 at 1,608 shares worth $350K. The position accounts for 0.17% of the portfolio, ranked #71.

Matrix Private Capital Group first reported a position in ABBV in Q4 2020 and has held it in 22 quarters since. The position peaked at $483K in Q1 2022. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Matrix Private Capital Group held 1,608 shares of AbbVie worth $350K as of Q1 2026.
  • Matrix Private Capital Group left its AbbVie share count unchanged in Q1 2026.
  • AbbVie made up 0.17% of Matrix Private Capital Group's portfolio in Q1 2026, its #71 holding.
  • Matrix Private Capital Group first reported a position in AbbVie in Q4 2020 and has held it in 22 quarters since.
  • Matrix Private Capital Group's AbbVie position peaked at $483K in Q1 2022.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Matrix Private Capital Group's 13F filing for Q1 2026, filed 15 May 2026.